Mutations in the TAZ gene cause Barth syndrome, but AAV9-hTZA gene therapy successfully reversed novel dysfunction in a cardio-specific Taz-knockout mouse model (81). The gene discussed is TAFAZZIN; the disease is Barth syndrome.